Chemotherapy in Hodgkin's disease.
To assess the efficacy of primary chemotherapy in patients with clinically staged Hodgkin's disease. Non randomized study. Pediatric Oncology Division of Regional Cancer Center. Twenty nine children with Hodgkin's disease. Chemotherapy was given to 21 patients whose parents agreed for the same. Sixteen children received COPP regimen and 5 received MOPP regimen. Complete remission was achieved in 19 patients. The relapse free survival and overall survival in these patients were 76% and 86%, respectively at 5 years. There was no death related to chemotherapy toxicity. Combination chemotherapy is an effective modality of treatment for children with Hodgkin's disease.